Following encouraging clinical results, retatrutide, a novel peptide option for treating adult-onset hyperglycemia , has obtained regulatory approval from UK’s Medicines and Healthcare Agency ( MHRA https://caranncv360269.luwebs.com/41851003/retatrutide-compound-peptide-british-approval-and-availability